Table 2.
Pathologic results and nodule size of patients who underwent thyroidectomy
| Patient | Age | Diagnosis at presentation | Nodule Size (mm) | First FNA (age-years) | First FNA Result | 2nd FNA age | Second FNA result | Surgery age | Pathology |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 14.9 | AT | 21 | 14.9 | papillary ca | 15.3 | papillary ca | ||
| 2 | 12.4 | Nodular goiter | 21 | 15.5 | Benign | 17.2 | papillary ca | 17.3 | papillary ca |
| 3 | 16.7 | AT | 5.3 | 16.8 | Chronic lymphocytic thyroiditis | 17.6 | papillary ca | 17.6 | papillary ca |
| 4 | 8 | Hypothyroidism | 9 | 12.5 | AUS/FLUS | 12.4 | papillary ca | ||
| 5 | 14.3 | Thyroid nodule | 18 | 14.5 | papillary ca | 17.3 | papillary ca | ||
| 6 | 7.3 | Thyroid nodule | 26 | 7.4 | papillary ca | 7.5 | papillary ca | ||
| 7 | 16.9 | Secondary hypothyroidism | 10 | 17.4 | papillary ca | 17.4 | papillary ca | ||
| 8 | 11.4 | AT | 8 | 12.8 | SM | 13 | papillary ca | ||
| 9 | 9 | Thyroid nodule | 33 | 9.1 | AUS/FLUS | 10.8 | papillary ca | 10 | papillary ca |
| 10 | 10 | Thyroid nodule | 4.4 | 10 | papillary ca | 10.3 | papillary ca | ||
| 11 | 10.3 | Osteomalacia, HL | 31 | 17.5 | SM | 17.7 | papillary ca | ||
| 12 | 13.2 | AT | 9 | 13.5 | SFN | 15.1 | papillary ca | ||
| 13 | 4.7 | Hodgkin Lymphoma |
5 | 14 | hyperplastic nodule | 15 | SFN | 16 | papillary ca |
| 14 | 14.2 | Thyroid nodule | 10 | 14.2 | AUS/FLUS | 14.2 | papillary ca | ||
| 15 | 12.6 | Thyroid nodule | 19 | 12.6 | SFN | 12.9 | papillary ca | ||
| 16 | 14.3 | Thyroid nodule | 19 | 14.3 | papillary ca | 14.3 | papillary ca | ||
| 17 | 9.1 | AT | 16 | 9.1 | Inadequate | 15.8 | Hyperplastic nodule | 16.3 | papillary ca |
| 18 | 16.1 | Thyroid nodule | 6.2 | 16.1 | papillary ca | 16.3 | papillary ca | ||
| 19 | 14.1 | Thyroid nodule | 37 | 14.3 | papillary ca | 14.3 | papillary ca | ||
| 20 | 8.6 | AT | 11 | 14.5 | papillary ca | 14.5 | papillary ca | ||
| 21 | 16.7 | AT | 5.3 | 17.4 | SM | 17.7 | papillary ca | ||
| 22 | 10.2 | AT | 9 | 10.7 | SM | 11.1 | papillary ca | ||
| 23 | 13.1 | AT, T1DM | 5 | 17.9 | SM | 17.9 | papillary ca | ||
| 24 | 16.9 | AT, Obesity | 10.6 | 17 | SM | 17.3 | papillary ca | ||
| 25 | 14.6 | Pons glioma, thyroid nodule | 5 | 14.7 | papillary ca | 14.8 | papillary ca | ||
| 26 | 14.1 | Liposarcoma, thyroid nodule | 5.8 | 19.5 | papillary ca | 19.5 | papillary ca | ||
| 27 | 18.3 | HL | 10 | 18.3 | SFN | 18.3 | papillary ca | ||
| 28 | 13.4 | Thyroid nodule | 18 | 13.4 | papillary ca | 13.4 | papillary ca | ||
| 29 | 12.8 | AT, T1DM | 8 | 15 | papillary ca | 15.2 | papillary ca | ||
| 30 | 10 | AT | 13 | 16.9 | hyperplastic nodule | 17.3 | SFN | 17.3 | papillary ca |
| 31 | 6 | Thyroid nodule | 27 | 6 | SFN | 6.3 | papillary ca | ||
| 32 | 12.5 | Thyroid nodule | 9.6 | 12.5 | Benign | 18 | Benign | 18 | Benign |
| 33 | 9.1 | Thyroid nodule | 24 | 10.2 | Benign | 11 | Benign | ||
| 34 | 11.7 | Thyroid nodule | 12 | 11.8 | SM | 12 | Benign | ||
| 35 | 1.7 | CH | 22 | 12.2 | SFN | 12.5 | Benign | ||
| 36 | 1.7 | CH | 16 | 13.1 | SFN | 13.1 | Benign | ||
| 37 | 0.1 | CH | 21 | 16.1 | Benign | 18.3 | Benign |
AT: autoimmune thyroiditis, CH: Congenital hypothyroidism, SFN: Suspicious of follicular neoplasia, T1DM: type 1 diabetes mellitus, HL: Hodgkin lymphoma, SM: Suspicious of malignancy.